Odiparcil QT Definitive Study
NCT00437242 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2012-06-04
Summary
This study is being completed to demonstrate the lack of effect of repeat dosing with Odiparcil on the QTc interval.
Conditions
- Fibrillation, Atrial
- Atrial Fibrillation
Interventions
- DRUG
-
Odiparcil
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
Countries
- United States
Study Locations
More Related Trials
-
To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women
NCT04281342 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
NCT05660720 ·Status: UNKNOWN ·Phase: PHASE1
-
Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)
NCT00751738 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects
NCT04250506 ·Status: COMPLETED ·Phase: PHASE1
-
TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects
NCT04168723 ·Status: UNKNOWN ·Phase: PHASE1
-
Staccato Prochlorperazine Thorough QT/QTc
NCT00543062 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult Participants
NCT03696459 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
NCT00353522 ·Status: COMPLETED ·Phase: PHASE2
-
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
NCT01483183 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function
NCT03657446 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants
NCT06194032 ·Status: COMPLETED ·Phase: PHASE1
-
DUTCH Weight Control in Atrial Fibrillation Study
NCT06184633 ·Status: RECRUITING ·Phase: PHASE4
-
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
NCT05724121 ·Status: RECRUITING
-
Effects of Single Oral Dose Dapagliflozin QT Study
NCT00688493 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
NCT03087487 ·Status: COMPLETED
-
A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)
NCT03606057 ·Status: COMPLETED ·Phase: PHASE1
-
A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers
NCT02236026 ·Status: COMPLETED ·Phase: PHASE1
-
Electrophysiological Effects of Potential QT Prolonging Drugs
NCT05716854 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
NCT03012828 ·Status: COMPLETED ·Phase: PHASE1
-
Staccato Loxapine Thorough QT/QTc Study
NCT00874237 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
NCT02069119 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects
NCT02807207 ·Status: COMPLETED ·Phase: PHASE1
-
A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization
NCT01941446 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants
NCT03494907 ·Status: COMPLETED ·Phase: PHASE1
-
Antiarrythmic Drugs - Long-term Follow-up in the Modern Era
NCT01082055 ·Status: COMPLETED